Abnormalities of erythropoiesis during HIV-1 disease: A longitudinal analysis

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 1, 2009, Pages 70-74

  Costantini, Andrea ^a,b   Giuliodoro, Simona ^a   Butini, Luca ^b   Silvestri, Guido ^c   Leoni, Pietro ^a,b   Montroni, Maria ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiretroviral therapy; BFU E; CD34 + hematopoietic stem cells; Erythropoiesis; HIV 1 infection

Indexed keywords

CD34 ANTIBODY; ERYTHROPOIETIN; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; IRON; METHYLCELLULOSE; STEM CELL FACTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; BURST FORMING UNIT E; CHRONIC DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOMAGNETIC SEPARATION; MALE; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-3; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; STEM CELL FACTOR;

EID: 69549103399     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181af65c5     Document Type: Article

References (19)

1. Bahner I, Kearns K, Coutinho S, et al. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood. 1997;90:1787-1798. (Pubitemid 27377288)
2. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 1998;91:1479-1495. (Pubitemid 28110310)
3. Neal TF, Holland HK, Baum CM, et al. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood. 1995;86:1749-1756.
4. Weichold FF, Zella D, Barabitskaja O, et al. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow culture. Blood. 1998;91:907-915. (Pubitemid 28078293)
5. Koka PS, Jamieson BD, Brooks DG, et al. Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J Virol. 1999;73:9089-9097. (Pubitemid 29487062)
6. Isgrò A, Mezzaroma I, Aiuti A, et al. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2000;16:1471-1479. (Pubitemid 30765742)
7. Isgrò A, Aiuti A, Leti W, et al. Immunodysregulation of HIV disease at bone marrow level. Autoimmun Rev. 2005;4:486-490. (Pubitemid 41415757)
8. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/. Accessed February 29, 2008.
9. Wang Z, Goldberg MA, Scadden DT. HIV-1 suppresses erythropoietin production in vitro. Exp Hematol. 1993;5:683-688. (Pubitemid 24212372)
10. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.
11. Weiss G. Iron and immunity: a double edged sword. Eur J Clin Invest. 2002;32(Suppl 1):70-78. (Pubitemid 41704991)
12. Levine A. Anemia in the setting of cancer and human immunodeficiency virus. Clin Infect Dis. 2003;37(Suppl 4):S304-S314. (Pubitemid 37431007)
13. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116:639-648.
14. Körbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med. 2003;349:570-582.
15. Kucia M, Ratajczak J, Ratajczak MZ. Are bone marrow stem cell plastic or heterogeneous - that is the question. Exp Hematol. 2005;33:613-623. (Pubitemid 40725827)
16. Jansen J, Hanks S, Thompson JM, et al. Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med. 2005;9:37-50.
17. Burt R, Pearce W, Luo K, et al. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplant. 2003;32(Suppl 1):S29-S31. (Pubitemid 37069506)
18. Kawabata Y, Hirokawa M, Komatsuda A, et al. Clinical applications of CD34+ cell-selected peripheral blood stem cells. Ther Apher Dial. 2003;7:298-304. (Pubitemid 36859518)
19. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987;317:192-197. (Pubitemid 17103099)